Artificial Intelligence (AI) Protein Design Market Report 2026

Artificial Intelligence (AI) Protein Design Market Overview

• Artificial Intelligence (AI) Protein Design market size has reached to $1.67 billion in 2025 • Expected to grow to $5.68 billion in 2030 at a compound annual growth rate (CAGR) of 27.7% • Growth Driver: The Increasing Focus On Biologics Is Fueling Market Growth Due To High Demand For Targeted Therapies • Market Trend: Advanced Deep-Learning Molecular Modeling Accelerates Protein Structure Prediction And Drug Discovery • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Artificial Intelligence (AI) Protein Design Market?

Artificial intelligence (AI) protein design refers to the use of machine learning algorithms and computational models to predict, create, and optimize protein structures with desired functions. It enables the design of novel proteins by analyzing vast biological data and identifying patterns in amino acid sequences and protein folding. This approach accelerates drug discovery, enzyme engineering, and biotechnology innovation by producing proteins that may not exist in nature. The main component types of artificial intelligence (AI) protein design include software, hardware, and services. Software refers to AI-driven platforms and computational tools used to design, optimize, and predict protein structures and functions. These solutions are used across protein types including enzymes, antibodies, therapeutic proteins, structural proteins, and signaling proteins and are deployed through on premises and cloud modes. The various applications involved are drug discovery, enzyme engineering, agricultural biotechnology, industrial biotechnology, and others, and they are used by several end users such as pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations, and others.

What Is The Artificial Intelligence (AI) Protein Design Market Growth Forecast?

The artificial intelligence (AI) protein design market size is expected to see exponential growth in the next few years. It will grow to $5.68 billion in 2030 at a compound annual growth rate (CAGR) of 27.7%. The growth in the forecast period can be attributed to rising adoption of AI-driven drug discovery platforms, increasing integration of cloud computing in life sciences research, growing demand for personalized and precision medicine solutions, expansion of synthetic biology and engineered protein applications, increasing use of quantum computing for molecular simulation and protein design. Major trends in the forecast period include AI-driven de novo protein structure prediction and optimization platforms, machine learning-based enzyme engineering for industrial and therapeutic applications, cloud-based protein modeling and bioinformatics simulation platforms, generative AI for custom therapeutic protein and antibody design, high-throughput computational protein screening and virtual testing systems.

Global Artificial Intelligence (AI) Protein Design Market Segmentation

1) By Component Type: Software, Hardware, Services 2) By Protein Type: Enzymes, Antibodies, Therapeutic Proteins, Structural Proteins, Signaling Proteins 3) By Deployment Mode: On Premises, Cloud 4) By Application: Drug Discovery, Enzyme Engineering, Agricultural Biotechnology, Industrial Biotechnology, Other Applications 5) By End User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations, Other End Users Subsegments: 1) By Software: Structure Prediction Software, Protein Modeling Software, Molecular Simulation Software, Drug Discovery Design Software, Data Analysis And Visualization Software, Machine Learning Model Development Software 2) By Hardware: High Performance Computing Systems, Graphics Processing Units Systems, Data Storage Systems, Quantum Computing Systems 3) By Services: Consulting Services, Integration And Deployment Services, Support And Maintenance Services, Training And Education Services, Custom Protein Design Services

What Is The Driver Of The Artificial Intelligence (AI) Protein Design Market?

The increasing focus on biologics is expected to propel the growth of the artificial intelligence (ai) protein design market going forward. Biologics are therapeutic products derived from living organisms or their components that target specific pathways in the immune system to treat diseases. The emphasis on biologics is growing due to advancements in biotechnology and immunology, which have enabled the development of more precise and effective treatments that target the underlying mechanisms of immune-mediated conditions rather than merely managing symptoms. Artificial intelligence (ai) protein design accelerates biologics development by enabling the rapid discovery and optimization of protein structures with improved therapeutic efficacy, stability, and target specificity. For instance, in February 2025, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, the 2023 WHO Essential Medicines List includes 81 biologic therapies, representing over 15% of all listed medicines. Therefore, the increasing focus on biologics is driving the growth of artificial intelligence (ai) protein design industry.

Key Players In The Global Artificial Intelligence (AI) Protein Design Market

Major companies operating in the artificial intelligence (ai) protein design market are Nvidia Corporation, DeepMind Technologies Limited, Schrödinger Inc., XtalPi Inc., Absci Corporation, Isomorphic Labs, Insilico Medicine Inc., Generate Biomedicines Inc., BenevolentAI Limited, EvolutionaryScale PBC, RosettaVIOLabs (Institute for Protein Design), Terray Therapeutics, Arzeda Corporation, Basecamp Research Ltd., Evozyne Inc., Profluent Bio Inc., Aqemia SAS, A-Alpha Bio Inc., Cradle Bio BV, Archon Biosciences Inc., Monod Bio Inc., Tamarind Bio Inc., Levitate Bio Inc., Denov Artificial Intelligence Biotech, Menten Artificial Intelligence Inc.

Global Artificial Intelligence (AI) Protein Design Market Trends and Insights

Major companies operating in the artificial intelligence (AI) protein design market are focusing on developing innovative solutions, such as advanced deep learning-based molecular modeling systems to accelerate accurate protein structure prediction, enhance drug discovery efficiency, and enable the design of novel therapeutics with improved precision. Advanced deep-learning based molecular modeling systems are AI-driven computational tools that use neural networks to simulate and predict the structures, behaviors, and interactions of molecules, such as proteins and drugs, with high accuracy to support scientific research and drug development. For instance, in May 2024, DeepMind Technologies Limited, a UK-based artificial intelligence research company, launched its latest protein structure prediction model, AlphaFold 3, which significantly advances the ability to model complex biomolecular interactions, including proteins, DNA, RNA, and small molecules. The system builds on previous versions by improving prediction accuracy and enabling a more comprehensive understanding of how biological molecules interact in real cellular environments. AlphaFold 3 leverages deep neural networks trained on large-scale biological datasets to generate highly accurate 3D protein structures, reducing reliance on time-consuming experimental methods such as X-ray crystallography and cryo-electron microscopy and thereby accelerating innovation in drug discovery and life sciences research.

What Are Latest Mergers And Acquisitions In The Artificial Intelligence (AI) Protein Design Market?

In January 2026, Insitro Inc., a US-based techbio company, acquired CombinAbleAI for an undisclosed amount. With this acquisition, insitro aims to strengthen and complete its full-stack, modality-agnostic AI platform for drug discovery and design by integrating advanced protein and molecular design capabilities. CombinAble.AI Ltd. is an Israel-based company that provides AI-driven protein and molecular design software solutions.

Regional Outlook

North America was the largest region in the artificial Intelligence (AI) protein design market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Artificial Intelligence (AI) Protein Design Market?

The artificial intelligence (AI) protein design market consists of revenues earned by entities by providing services such as de novo protein design, antibody discovery, protein structure prediction, molecular dynamics simulation services, and protein-ligand interaction modeling. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) protein design market also includes sales of rack-scale compute systems, edge AI compute device, molecular simulation workstations, and automated protein synthesis systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Artificial Intelligence (AI) Protein Design Market Report 2026?

The artificial intelligence (AI) protein design market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI) protein design market statistics, including artificial intelligence (AI) protein design industry global market size, regional shares, competitors with a artificial intelligence (AI) protein design market share, detailed artificial intelligence (AI) protein design market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) protein design industry. This artificial intelligence (AI) protein design market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.